Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 14/2022

29-04-2022 | Buprenorphine | Concise Research Report

Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries

Authors: Sadiq Y. Patel, PhD MS MSW, Esteban G. Ortiz, BS, Benjamin A. Barsky, JD, Haiden A. Huskamp, PhD, Alisa B. Busch, MD MS, Ateev Mehrotra, MD MPH

Published in: Journal of General Internal Medicine | Issue 14/2022

Login to get access

Excerpt

The 2008 Ryan Haight Act generally requires an in-person medical evaluation before the prescribing of medications such as buprenorphine for opioid use disorder (MOUD).1,2 Early in the COVID-19 pandemic (March 2020), the requirement was temporarily waived3 and there was a sharp increase in MOUD inductions via telemedicine.4 …
Literature
1.
2.
3.
4.
5.
6.
Metadata
Title
Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
Authors
Sadiq Y. Patel, PhD MS MSW
Esteban G. Ortiz, BS
Benjamin A. Barsky, JD
Haiden A. Huskamp, PhD
Alisa B. Busch, MD MS
Ateev Mehrotra, MD MPH
Publication date
29-04-2022
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 14/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-022-07633-y

Other articles of this Issue 14/2022

Journal of General Internal Medicine 14/2022 Go to the issue

Original Research

Incidence and Predictors of Primary Nonadherence to Sodium Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Agonists in a Large Integrated Healthcare System

Original Research

Association of State-Imposed Restrictions on Gabapentin with Changes in Prescribing in Medicare

Original Research

Taking ACTION to Reduce Pain: a Randomized Clinical Trial of a Walking-Focused, Proactive Coaching Intervention for Black Patients with Chronic Musculoskeletal Pain

Viewpoint

Evidence synthesis practice: why we cannot ignore studies with no events?

Original Research

The Heart and Cannabis (THC) Cohort: Differences in Baseline Health and Behaviors by Cannabis Use

Original Research: Qualitative Research

Expert Recommendations for Designing Reporting Systems to Address Patient-Perpetrated Sexual Harassment in Healthcare Settings

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits